Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Rahul R Aggarwal"'
Autor:
Li Zhang, Lawrence Fong, David Y Oh, Eliezer Van Allen, Felix Y Feng, Anthony Wong, Eric J Small, Terence W Friedlander, Alec Starzinski, Zenghua Fan, Tony Li, Hewitt Chang, Marissa Gin, Katsuto Shinohara, Hao Nguyen, Caleb Hwang, Christopher De Leon, Rahul R Aggarwal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0340aac11ac1489581066e7c00216656
Autor:
Daniel H. Kwon, Lauren Trihy, Nika Darvish, Eliza Hearst, Saffanat Sumra, Hala T. Borno, Rohit Bose, Jonathan Chou, Ivan deKouchkovsky, Arpita Desai, Brad Ekstrand, Terence Friedlander, Gurleen Kaur, Vadim S. Koshkin, Samantha Nesheiwat, Karen Sepucha, Eric J. Small, Rahul R. Aggarwal, Jeffrey Belkora
Publikováno v:
Cancer Medicine, Vol 13, Iss 22, Pp n/a-n/a (2024)
ABSTRACT Introduction Consultation audio recordings improve patient decision‐making but are underutilized. Patient‐administered recording apps on mobile devices may increase access, but implementation has not been evaluated. Methods We conducted
Externí odkaz:
https://doaj.org/article/0d02c450ed2a4fcf8034fd1bda9396bd
Autor:
Janice M. Mehnert, Andrea Varga, Marcia S. Brose, Rahul R. Aggarwal, Chia-Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina A. Piha-Paul, Jill Gilbert, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Bhumsuk Keam
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Treatment options for advanced thyroid cancer refractory to standard therapies are limited. The safety and efficacy of pembrolizumab were evaluated in patients with advanced differentiated thyroid cancer expressing programmed deat
Externí odkaz:
https://doaj.org/article/ef601229f665405fbfaf2b01ef546063
Autor:
Daniel H. Kwon, Kelly M. Gordon, Barry Tong, Hala T. Borno, Makenna Beigh, Delaire Fattah, Alexandra Schleicher, Rahul R. Aggarwal, Amie M. Blanco, Eric J. Small, Mallika Dhawan
Publikováno v:
JCO Oncology Practice. 19:e773-e783
PURPOSE: Germline testing for men with prostate cancer (PCa) poses numerous implementation barriers. Alternative models of care delivery are emerging, but implementation outcomes are understudied. We evaluated implementation outcomes of a hybrid onco
Autor:
Erica S. Tsang, Rahul R. Aggarwal, Mallika S. Dhawan, Emily K. Bergsland, Edwin A. Alvarez, Susan Calabrese, Romain Pacaud, Jose Garcia, Delaire Fattah, Scott Thomas, Jennifer Grabowsky, Mark M. Moasser, Pamela N. Munster
Publikováno v:
Cancer Research Communications. 2:570-576
The PI3K pathway may be a potential mechanism to overcome cisplatin resistance. We conducted a phase Ib trial of alpelisib and cisplatin for patients with solid tumor malignancies with planned dose expansion in HPV-associated tumors. The primary obje
Autor:
Nitya Raj, Jennifer A. Chan, Stephanie J. Wang, Rahul R. Aggarwal, Susan Calabrese, April DeMore, Lawrence Fong, Jennifer Grabowsky, Thomas A. Hope, Kanti Pallav Kolli, Claire K. Mulvey, Pamela N. Munster, Kimberly Perez, Sippy Punn, Diane Reidy-Lagunes, Sofia Von Fedak, Li Zhang, Emily K. Bergsland
Publikováno v:
British Journal of Cancer.
Autor:
Pamela N. Munster, Mark M. Moasser, Jennifer Grabowsky, Scott Thomas, Delaire Fattah, Jose Garcia, Romain Pacaud, Susan Calabrese, Edwin A. Alvarez, Emily K. Bergsland, Mallika S. Dhawan, Rahul R. Aggarwal, Erica S. Tsang
The PI3K pathway may be a potential mechanism to overcome cisplatin resistance. We conducted a phase Ib trial of alpelisib and cisplatin for patients with solid tumor malignancies with planned dose expansion in HPV-associated tumors. The primary obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5185da53f97a26f3cf85290739ff67de
https://doi.org/10.1158/2767-9764.c.6550920.v1
https://doi.org/10.1158/2767-9764.c.6550920.v1
Autor:
Pamela N. Munster, Mark M. Moasser, Jennifer Grabowsky, Scott Thomas, Delaire Fattah, Jose Garcia, Romain Pacaud, Susan Calabrese, Edwin A. Alvarez, Emily K. Bergsland, Mallika S. Dhawan, Rahul R. Aggarwal, Erica S. Tsang
A) Rationale for study drug dose interruption or reduction; B) Rationale for cisplatin dose interruption or reduction; C) Cisplatin dose intensity, stratified by dose level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15538f083c9f21c5743c59ccfc7bbc42
https://doi.org/10.1158/2767-9764.22545363.v1
https://doi.org/10.1158/2767-9764.22545363.v1
Autor:
Eric J. Small, Joshi J. Alumkal, Felix Y. Feng, Primo N. Lara, Christopher P. Evans, Kim N. Chi, Paul Lloyd, Denise Playdle, Adam Foye, George V. Thomas, Martin E. Gleave, Rob E. Reiter, Matthew B. Rettig, Tomasz M. Beer, Li Zhang, Jiaoti Huang, David A. Quigley, Rahul R. Aggarwal
Supplementary Table 2. Clinical Characteristics of the Evaluable Paired Biopsy Cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::286e14562340f1dbbad7642c122a93ec
https://doi.org/10.1158/1541-7786.22512501.v1
https://doi.org/10.1158/1541-7786.22512501.v1
Autor:
Eric J. Small, Joshi J. Alumkal, Felix Y. Feng, Primo N. Lara, Christopher P. Evans, Kim N. Chi, Paul Lloyd, Denise Playdle, Adam Foye, George V. Thomas, Martin E. Gleave, Rob E. Reiter, Matthew B. Rettig, Tomasz M. Beer, Li Zhang, Jiaoti Huang, David A. Quigley, Rahul R. Aggarwal
Supplementary Table 1. Clinical Characteristics of the Whole Genome Sequencing Cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::543013214e929e2d99d7cbe10d8f4a33
https://doi.org/10.1158/1541-7786.22512504
https://doi.org/10.1158/1541-7786.22512504